First Trust Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $840M | Sell |
3,388,725
-126,368
| -4% | -$27.2M | 0.49% | 22 |
|
|
2026
Q1 | $706M | Buy |
3,515,093
+3,508,029
| +49,661% | +$726M | 0.5% | 25 |
|
|
2025
Q4 | $1.46M | Sell |
7,064
-1,254
| -15% | -$251K | ﹤0.01% | 2021 |
|
|
2025
Q3 | $1.49M | Sell |
8,318
-75
| -0.9% | -$12.8K | ﹤0.01% | 1961 |
|
|
2025
Q2 | $1.35M | Buy |
8,393
+66
| +0.8% | +$10.5K | ﹤0.01% | 1977 |
|
|
2025
Q1 | $1.42M | Buy |
8,327
+1,335
| +19% | +$232K | ﹤0.01% | 1918 |
|
|
2024
Q4 | $1.16M | Sell |
6,992
-894
| -11% | -$153K | ﹤0.01% | 2015 |
|
|
2024
Q3 | $1.36M | Buy |
7,886
+1,504
| +24% | +$249K | ﹤0.01% | 1919 |
|
|
2024
Q2 | $983K | Sell |
6,382
-2,568
| -29% | -$385K | ﹤0.01% | 1957 |
|
|
2024
Q1 | $1.38M | Sell |
8,950
-1,243
| -12% | -$190K | ﹤0.01% | 1883 |
|
|
2023
Q4 | $1.61M | Sell |
10,193
-2
| -0% | -$287 | ﹤0.01% | 1813 |
|
|
2023
Q3 | $1.49M | Sell |
10,195
-2,524
| -20% | -$385K | ﹤0.01% | 1811 |
|
|
2023
Q2 | $1.95M | Buy |
12,719
+9
| +0.1% | +$1.4K | ﹤0.01% | 1716 |
|
|
2023
Q1 | $1.97M | Buy |
12,710
+1,269
| +11% | +$199K | ﹤0.01% | 1691 |
|
|
2022
Q4 | $1.76M | Buy |
11,441
+1,243
| +12% | +$183K | ﹤0.01% | 1748 |
|
|
2022
Q3 | $1.34M | Buy |
10,198
+1,251
| +14% | +$176K | ﹤0.01% | 1877 |
|
|
2022
Q2 | $1.21M | Sell |
8,947
-18
| -0.2% | -$2.48K | ﹤0.01% | 1914 |
|
|
2022
Q1 | $1.34M | Buy |
8,965
+5,027
| +128% | +$744K | ﹤0.01% | 1939 |
|
|
2021
Q4 | $638K | Sell |
3,938
-310
| -7% | -$50.1K | ﹤0.01% | 2218 |
|
|
2021
Q3 | $705K | Sell |
4,248
-1,414
| -25% | -$242K | ﹤0.01% | 2164 |
|
|
2021
Q2 | $977K | Buy |
5,662
+1,365
| +32% | +$225K | ﹤0.01% | 2070 |
|
|
2021
Q1 | $690K | Buy |
+4,297
| New | +$736K | ﹤0.01% | 2104 |
|
|
2019
Q3 | – | Sell |
-4,105,258
| Closed | -$578M | – | 2414 |
|
|
2019
Q2 | $578M | Buy |
4,105,258
+449,629
| +12% | +$62M | 1.09% | 5 |
|
|
2019
Q1 | $551M | Sell |
3,655,629
-441,133
| -11% | -$63.5M | 1.1% | 10 |
|
|
2018
Q4 | $509M | Sell |
4,096,762
-373,352
| -8% | -$51.1M | 1.21% | 8 |
|
|
2018
Q3 | $708M | Buy |
+4,470,114
| New | +$676M | 1.32% | 3 |
|
|
2016
Q1 | – | Sell |
-10,731,173
| Closed | -$1.21B | – | 2235 |
|
|
2015
Q4 | $1.21B | Buy |
10,731,173
+1,020,582
| +11% | +$110M | 3.15% | 1 |
|
|
2015
Q3 | $984M | Buy |
9,710,591
+1,635,000
| +20% | +$194M | 2.85% | 1 |
|
|
2015
Q2 | $1B | Buy |
8,075,591
+2,278,536
| +39% | +$275M | 2.6% | 1 |
|
|
2015
Q1 | $685M | Buy |
5,797,055
+2,723,256
| +89% | +$308M | 2.01% | 1 |
|
|
2014
Q4 | $314M | Buy |
3,073,799
+1,619,304
| +111% | +$158M | 1.06% | 1 |
|
|
2014
Q3 | $133M | Buy |
1,454,495
+578,136
| +66% | +$50.2M | 0.53% | 8 |
|
|
2014
Q2 | $72.2M | Buy |
876,359
+591,216
| +207% | +$45.2M | 0.3% | 42 |
|
|
2014
Q1 | $21.9M | Buy |
+285,143
| New | +$22.2M | 0.1% | 285 |
|
Other funds holding FBT
BFG
NP
First Trust Advisors's FBT Position: Q2 2026 in Review
First Trust Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.6% in Q2 2026, selling an estimated $27.2M and leaving 3,388,725 shares worth $840M. The position accounts for 0.49% of the portfolio, ranked #22.
First Trust Advisors first reported a position in FBT in Q1 2014 and has held it in 34 quarters since. The position peaked at $1.21B in Q4 2015. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- First Trust Advisors held 3,388,725 shares of First Trust NYSE Arca Biotechnology Index Fund worth $840M as of Q2 2026.
- First Trust Advisors sold 126,368 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $27.2M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.49% of First Trust Advisors's portfolio in Q2 2026, its #22 holding.
- First Trust Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2014 and has held it in 34 quarters since.
- First Trust Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.21B in Q4 2015.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.